Loading…
Loading…
ACLS does not currently pay a dividend.
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
Click below to see what's inside, then upgrade to unlock for ACLS and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for ACLS and 80,000+ other tickers.
See exactly how ACLS's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for ACLS and 80,000+ other tickers.
Axcelis Technologies, Inc. is a company dedicated to the creation, production, and maintenance of specialized ion implantation and other essential processing machinery used in the fabrication of semiconductor chips. Operating internationally, its presence extends across North America, Europe, and Asia. The firm offers a wide array of implanter technologies, such as high-energy, high-current, and medium-current systems, designed to meet diverse application needs. Furthermore, Axcelis provides extensive post-sales support and lifecycle solutions, including the sale of pre-owned equipment…
BEVERLY, Mass., Sept. 1, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced the company's plans to participate in the following upcoming investor conferences: The Citi 2026 Global TMT Conference on Tuesday, September 8th at the New York Hilton Midtown.
Investors need to pay close attention to ACLS stock based on the movements in the options market lately.
Business is accelerating at the perfect moment.
Cetera Investment Advisers trimmed its position in Axcelis Technologies, Inc. (NASDAQ: ACLS) by 48.5% during the first quarter, according to its most recent 13F filing with the SEC. The fund owned 5,127 shares of the semiconductor company's stock after selling 4,828 shares during the period. Cetera Investment Advisers' holdings in Axcelis Technologies were
On August 18, 2026, Axcelis Technologies Inc (ACLS) shares fell 5.9%, bringing the current price to $135.36. Over the past year, the stock has seen a high of $1